A prospective observational study evaluating the efficacy of hepatitis B virus vaccines HBVaxpro40 and Fendrix in patients with chronic liver disease
Latest Information Update: 18 Aug 2021
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; Hepatitis B vaccine recombinant (HBvaxPro) (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics; Therapeutic Use
- 18 Aug 2021 New trial record
- 26 Jun 2021 Results presented at The International Liver Congress 2021